Engineering Peptide Modulators for T-Cell Migration by Structural Scaffold Matching.

Area of Science:

• Immunology
• Structural Biology
• Medicinal Chemistry

Background:

• Lymphocyte migration is critical in autoimmune and inflammatory diseases.
• Inhibiting autoreactive immune cells presents a therapeutic opportunity.
• Pepitem is an endogenous modulator of lymphocyte migration.

Purpose of the Study:

• To engineer stabilized pepitem-based probes for inhibiting lymphocyte migration.
• To overcome challenges associated with flexible and linear peptides in therapeutic design.

Main Methods:

• Utilized a structural scaffold matching approach to identify suitable peptide scaffolds.
• Mined protein structure databases to find structures mimicking pepitem's helix-loop-helix motif.
• Developed and tested VhTI-pep 2 for its ability to inhibit CD3+ T-lymphocyte migration.

Main Results:

• Developed VhTI-pep 2, a stabilized pepitem-based probe.
• VhTI-pep 2 demonstrated comparable potency to pepitem in inhibiting CD3+ T-lymphocyte migration (EC50 = 10.6 ± 16.5 nM vs. 6.0 ± 6.4 nM).
• The probe's efficacy extended to T-cell subsets from multiple sclerosis patients, including memory and Th1 cells.

Conclusions:

• The structural scaffold matching approach successfully yielded stabilized peptide probes.
• VhTI-pep 2 is a potent inhibitor of T-lymphocyte migration, relevant to autoimmune diseases.
• This strategy provides a foundation for designing novel peptide therapeutics targeting lymphocyte migration.